{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T17:03:13Z","timestamp":1790960593025,"version":"4.1.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T00:00:00Z","timestamp":1692230400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.clim.2023.109740","type":"journal-article","created":{"date-parts":[[2023,8,14]],"date-time":"2023-08-14T21:04:53Z","timestamp":1692047093000},"page":"109740","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Clinical correlates of a subset of anti-fibroblast antibodies in systemic sclerosis"],"prefix":"10.1016","volume":"255","author":[{"given":"Elvira","family":"Favoino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Cipriani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasiliki","family":"Liakouli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Addolorata","family":"Corrado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Navarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Vomero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Sisto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa Daniela","family":"Grembiale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Ciccia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco P.","family":"Cantatore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piero","family":"Ruscitti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Giacomelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Perosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.clim.2023.109740_bb0005","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1172\/JCI31139","article-title":"Systemic sclerosis: a prototypic multisystem fibrotic disorder","volume":"117","author":"Varga","year":"2007","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.clim.2023.109740_bb0010","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.semarthrit.2007.10.010","article-title":"The immunobiology of systemic sclerosis","volume":"38","author":"Gu","year":"2008","journal-title":"Semin. Arthritis Rheum."},{"issue":"10","key":"10.1016\/j.clim.2023.109740_bb0015","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1136\/ard.2009.114264","article-title":"Causes and risk factors for death in systemic sclerosis: a study from the EULAR scleroderma trials and research (EUSTAR) database","volume":"69","author":"Tyndall","year":"2010","journal-title":"Ann. Rheum. Dis."},{"issue":"2","key":"10.1016\/j.clim.2023.109740_bb0020","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.semarthrit.2014.05.010","article-title":"Mortality and survival in systemic sclerosis: systematic review and meta-analysis","volume":"44","author":"Rubio-Rivas","year":"2014","journal-title":"Semin. Arthritis Rheum."},{"issue":"8","key":"10.1016\/j.clim.2023.109740_bb0025","doi-asserted-by":"crossref","DOI":"10.3390\/biom12081096","article-title":"Circulating Irisin levels in patients with chronic plaque psoriasis","volume":"12","author":"Ambrogio","year":"2022","journal-title":"Biomolecules"},{"issue":"7","key":"10.1016\/j.clim.2023.109740_bb0030","doi-asserted-by":"crossref","first-page":"3649","DOI":"10.4049\/jimmunol.168.7.3649","article-title":"Oligoclonal T cell expansion in the skin of patients with systemic sclerosis","volume":"168","author":"Sakkas","year":"2002","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.clim.2023.109740_bb0035","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1365-2249.2006.03041.x","article-title":"Peripheral T lymphocytes from patients with early systemic sclerosis co-cultured with autologous fibroblasts undergo an oligoclonal expansion similar to that occurring in the skin","volume":"144","author":"De Palma","year":"2006","journal-title":"Clin. Exp. Immunol."},{"issue":"7","key":"10.1016\/j.clim.2023.109740_bb0040","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1093\/rheumatology\/keq094","article-title":"Peripheral T cells from patients with early systemic sclerosis kill autologous fibroblasts in co-culture: is T-cell response aimed to play a protective role?","volume":"49","author":"De Palma","year":"2010","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"10.1016\/j.clim.2023.109740_bb0045","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1002\/art.10361","article-title":"Autoantibodies to fibroblasts induce a proadhesive and proinflammatory fibroblast phenotype in patients with systemic sclerosis","volume":"46","author":"Chizzolini","year":"2002","journal-title":"Arthritis Rheum."},{"issue":"2","key":"10.1016\/j.clim.2023.109740_bb0050","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.autrev.2007.02.020","article-title":"Stimulatory autoantibodies to the PDGF receptor: a link to fibrosis in scleroderma and a pathway for novel therapeutic targets","volume":"7","author":"Gabrielli","year":"2007","journal-title":"Autoimmun. Rev."},{"issue":"6","key":"10.1016\/j.clim.2023.109740_bb0055","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1002\/art.10362","article-title":"Antifibroblast antibodies from systemic sclerosis patients are internalized by fibroblasts via a caveolin-linked pathway","volume":"46","author":"Ronda","year":"2002","journal-title":"Arthritis Rheum."},{"issue":"7","key":"10.1016\/j.clim.2023.109740_bb0060","doi-asserted-by":"crossref","first-page":"4555","DOI":"10.4049\/jimmunol.175.7.4555","article-title":"Autoantibodies to fibrillin-1 activate normal human fibroblasts in culture through the TGF-beta pathway to recapitulate the \u201cscleroderma phenotype\u201d","volume":"175","author":"Zhou","year":"2005","journal-title":"J. Immunol."},{"issue":"25","key":"10.1016\/j.clim.2023.109740_bb0065","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1056\/NEJMoa052955","article-title":"Stimulatory autoantibodies to the PDGF receptor in systemic sclerosis","volume":"354","author":"Baroni","year":"2006","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.clim.2023.109740_bb0070","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1164\/rccm.200707-1015OC","article-title":"Identification of target antigens of antifibroblast antibodies in pulmonary arterial hypertension","volume":"177","author":"Terrier","year":"2008","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"2","key":"10.1016\/j.clim.2023.109740_bb0075","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1136\/ard.2008.104299","article-title":"Antifibroblast antibodies from systemic sclerosis patients bind to {alpha}-enolase and are associated with interstitial lung disease","volume":"69","author":"Terrier","year":"2010","journal-title":"Ann. Rheum. Dis."},{"issue":"11","key":"10.1016\/j.clim.2023.109740_bb0080","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/art.38098","article-title":"Classification criteria for systemic sclerosis: an American College of Rheumatology\/European league against rheumatism collaborative initiative","volume":"65","author":"Van Den","year":"2013","journal-title":"Arthritis Rheum."},{"issue":"6","key":"10.1016\/j.clim.2023.109740_bb0085","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1136\/ard.2006.062901","article-title":"Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR scleroderma trials and research group database","volume":"66","author":"Walker","year":"2007","journal-title":"Ann. Rheum. Dis."},{"issue":"2","key":"10.1016\/j.clim.2023.109740_bb0090","first-page":"202","article-title":"Scleroderma (systemic sclerosis): classification, subsets and pathogenesis","volume":"15","author":"LeRoy","year":"1988","journal-title":"J. Rheumatol."},{"issue":"1","key":"10.1016\/j.clim.2023.109740_bb0095","doi-asserted-by":"crossref","first-page":"416","DOI":"10.4049\/jimmunol.182.1.416","article-title":"Two structurally different rituximab-specific CD20 mimotope peptides reveal that rituximab recognizes two different CD20-associated epitopes","volume":"182","author":"Perosa","year":"2009","journal-title":"J. Immunol."},{"issue":"10","key":"10.1016\/j.clim.2023.109740_bb0100","first-page":"1956","article-title":"Novel biomarker for pulmonary vascular disease in systemic sclerosis patients","volume":"40","author":"Favoino","year":"2022","journal-title":"Clin. Exp. Rheumatol."},{"issue":"3","key":"10.1016\/j.clim.2023.109740_bb0105","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1182\/blood-2005-04-1769","article-title":"Generation of biologically active linear and cyclic peptides has revealed a unique fine specificity of rituximab and its possible cross-reactivity with acid sphingomyelinase-like phosphodiesterase 3b precursor","volume":"107","author":"Perosa","year":"2006","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.clim.2023.109740_bb0110","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.ajpath.2012.10.021","article-title":"Human leukocyte antigen-G is frequently expressed in glioblastoma and may be induced in vitro by combined 5-aza-2\u2032-deoxycytidine and interferon-\u03b3 treatments: results from a multicentric study","volume":"182","author":"Wastowski","year":"2013","journal-title":"Am. J. Pathol."},{"issue":"12","key":"10.1016\/j.clim.2023.109740_bb0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0210023","article-title":"Anti-carbamylated protein antibodies and skin involvement in patients with systemic sclerosis: an intriguing association","volume":"13","author":"Favoino","year":"2018","journal-title":"PLoS One"},{"issue":"25","key":"10.1016\/j.clim.2023.109740_bb0120","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000003931","article-title":"Subspecificities of anticentromeric protein a antibodies identify systemic sclerosis patients at higher risk of pulmonary vascular disease","volume":"95","author":"Perosa","year":"2016","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"10.1016\/j.clim.2023.109740_bb0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0061453","article-title":"Autoantibodies recognizing the amino terminal 1-17 segment of CENP-A display unique specificities in systemic sclerosis","volume":"8","author":"Favoino","year":"2013","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.clim.2023.109740_bb0130","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20081920","article-title":"CD20-Mimotope peptides: a model to define the molecular basis of epitope spreading","volume":"20","author":"Favoino","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.clim.2023.109740_bb0135","doi-asserted-by":"crossref","first-page":"R72","DOI":"10.1186\/ar4249","article-title":"Clinical correlates of a subset of anti-CENP-A antibodies cross-reacting with FOXE3p53-62 in systemic sclerosis","volume":"15","author":"Perosa","year":"2013","journal-title":"Arthritis Res. Ther."},{"issue":"2","key":"10.1016\/j.clim.2023.109740_bb0140","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.semarthrit.2014.05.010","article-title":"Mortality and survival in systemic sclerosis: systematic review and meta-analysis","volume":"44","author":"Rubio-Rivas","year":"2014","journal-title":"Semin. Arthritis Rheum."},{"issue":"10103","key":"10.1016\/j.clim.2023.109740_bb0145","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/S0140-6736(17)30933-9","article-title":"Systemic sclerosis","volume":"390","author":"Denton","year":"2017","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.clim.2023.109740_bb0150","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1093\/rheumatology\/kez230","article-title":"Biomarkers in systemic sclerosis-associated interstitial lung disease: review of the literature","volume":"58","author":"Bonhomme","year":"2019","journal-title":"Rheumatology (Oxford)"},{"issue":"135","key":"10.1016\/j.clim.2023.109740_bb0155","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1183\/09059180.00003214","article-title":"Cellular interactions in the pathogenesis of interstitial lung diseases","volume":"24","author":"Bagnato","year":"2015","journal-title":"Eur. Respir. Rev."},{"issue":"12","key":"10.1016\/j.clim.2023.109740_bb0160","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1093\/rheumatology\/kem241","article-title":"Anti-fibroblast antibodies detected by cell-based ELISA in systemic sclerosis enhance the collagenolytic activity and matrix metalloproteinase-1 production in dermal fibroblasts","volume":"46","author":"Fineschi","year":"2007","journal-title":"Rheumatology (Oxford)"},{"issue":"12","key":"10.1016\/j.clim.2023.109740_bb0165","doi-asserted-by":"crossref","first-page":"3913","DOI":"10.1002\/art.24049","article-title":"Antifibroblast antibodies in systemic sclerosis induce fibroblasts to produce profibrotic chemokines, with partial exploitation of toll-like receptor 4","volume":"58","author":"Fineschi","year":"2008","journal-title":"Arthritis Rheum."},{"issue":"3","key":"10.1016\/j.clim.2023.109740_bb0170","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/art.41153","article-title":"Using autoantibodies and cutaneous subset to develop outcome-based disease classification in systemic sclerosis","volume":"72","author":"Nihtyanova","year":"2020","journal-title":"Arthritis Rheum."},{"issue":"5","key":"10.1016\/j.clim.2023.109740_bb0175","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1002\/pmic.200700794","article-title":"Identification of target antigens of antiendothelial cell antibodies in healthy individuals: a proteomic approach","volume":"8","author":"Servettaz","year":"2008","journal-title":"Proteomics"},{"issue":"3","key":"10.1016\/j.clim.2023.109740_bb0180","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1046\/j.1365-2249.1998.00583.x","article-title":"Identification and characterization of autoantibodies against catalase and alpha-enolase in patients with primary sclerosing cholangitis","volume":"112","author":"Orth","year":"1998","journal-title":"Clin. Exp. Immunol."},{"issue":"1","key":"10.1016\/j.clim.2023.109740_bb0185","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1046\/j.1365-2249.1998.00528.x","article-title":"Catalase and alpha-enolase: two novel granulocyte autoantigens in inflammatory bowel disease (IBD)","volume":"112","author":"Roozendaal","year":"1998","journal-title":"Clin. Exp. Immunol."},{"issue":"5","key":"10.1016\/j.clim.2023.109740_bb0190","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1002\/art.10252","article-title":"Presence of autoantibodies to the glycolytic enzyme alpha-enolase in sera from patients with early rheumatoid arthritis","volume":"46","author":"Saulot","year":"2002","journal-title":"Arthritis Rheum."},{"issue":"7","key":"10.1016\/j.clim.2023.109740_bb0195","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1002\/art.11074","article-title":"Human alpha-enolase from endothelial cells as a target antigen of anti-endothelial cell antibody in Beh\u00c3\u00a7et\u2019s disease","volume":"48","author":"Lee","year":"2003","journal-title":"Arthritis Rheum."},{"issue":"5","key":"10.1016\/j.clim.2023.109740_bb0200","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1002\/pmic.200700794","article-title":"Identification of target antigens of antiendothelial cell antibodies in healthy individuals: a proteomic approach","volume":"8","author":"Servettaz","year":"2008","journal-title":"Proteomics"},{"issue":"6","key":"10.1016\/j.clim.2023.109740_bb0205","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1002\/art.38390","article-title":"Prediction of pulmonary complications and long-term survival in systemic sclerosis","volume":"66","author":"Nihtyanova","year":"2014","journal-title":"Arthritis Rheum."},{"issue":"7","key":"10.1016\/j.clim.2023.109740_bb0210","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1093\/rheumatology\/keac639","article-title":"Risk factors for lung function decline in systemic sclerosis-associated interstitial lung disease in a large single-center cohort","volume":"62","author":"Ramahi","year":"2023","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"10.1016\/j.clim.2023.109740_bb0215","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1378\/chest.13-2626","article-title":"Predictors of mortality and progression in scleroderma-associated interstitial lung disease: a systematic review","volume":"146","author":"Winstone","year":"2014","journal-title":"Chest"},{"issue":"11","key":"10.1016\/j.clim.2023.109740_bb0220","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.3899\/jrheum.140156","article-title":"Lung function and survival in systemic sclerosis interstitial lung disease","volume":"41","author":"Ahmed","year":"2014","journal-title":"J. Rheumatol."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152166162300503X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152166162300503X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:10:21Z","timestamp":1761495021000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152166162300503X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":44,"alternative-id":["S152166162300503X"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2023.109740","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical correlates of a subset of anti-fibroblast antibodies in systemic sclerosis","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2023.109740","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"109740"}}